Cyrille Pauthenier, Founder, Owner & CEO

Professional Overview

Cyrille Pauthenier is an accomplished biotechnology entrepreneur and industry leader with extensive expertise in the fields of synthetic biology and microbiome research. As the Founder, Owner, and CEO of Abolis Biotechnologies, he spearheads the development of innovative biotechnology solutions that address pressing challenges in various industries. Additionally, Cyrille is the Founder and President of Microbiome Studio, a pioneering venture dedicated to advancing the understanding and applications of the human microbiome.

Experience Summary

Current Roles

Founder, Owner & CEO, Abolis Biotechnologies (2014-01-01 to Present)

Oversees the strategic direction and day-to-day operations of Abolis Biotechnologies, a leading biotechnology company focused on developing cutting-edge solutions in synthetic biology and microbiome research.

Drives the company's R&D efforts, leading a team of highly skilled scientists and engineers in the development of innovative technologies and products.

Secures funding and strategic partnerships to fuel the company's growth and expand its market reach, contributing to its industry recognition and impact.

Founder & Président, Microbiome Studio (2022-01-01 to Present)

Leads the vision and strategic development of Microbiome Studio, a pioneering venture dedicated to advancing the understanding and applications of the human microbiome.

Fosters collaborations with renowned academic institutions and industry partners to drive cutting-edge research and translate scientific discoveries into practical solutions.

Oversees the organization's operations, resource allocation, and talent development to ensure the successful execution of its mission and objectives.

Career Progression

Prior to his entrepreneurial ventures, Cyrille Pauthenier gained valuable experience through various academic and research positions:

PHD Graduate Student, Université Paris-Saclay - Institute of System & Synthetic Biology (2012-10-01 to 2016-11-01): Conducted groundbreaking research in the field of synthetic biology, contributing to the advancement of the field through his scientific contributions.

Intern, Michelle Chang laboratory at UC Berkeley (2012-01-01 to 2012-01-01): Gained exposure to cutting-edge research and collaboration in a renowned academic institution, further developing his expertise in biotechnology.

Intern, Miquel Pons laboratory at IRB Barcelona (2011-03-01 to 2011-01-01): Participated in research projects focused on the intersection of biotechnology and sustainability, broadening his understanding of the industry's diverse applications.

Intern, Hervé le Hir laboratory at École normale supérieure (2010-05-01 to 2010-07-01): Contributed to research initiatives in the field of molecular biology, honing his technical skills and scientific acumen.

Intern, Jean-Maurice Mallet Laboratory (2009-10-01 to 2009-11-01): Gained early-career experience in a research setting, laying the foundation for his future accomplishments in the biotechnology industry.

Academic Background

Cyrille Pauthenier holds a Ph.D. in Synthetic Biology from the Université Paris-Saclay - Institute of System & Synthetic Biology, where he conducted groundbreaking research and contributed to the advancement of the field.

Areas of Expertise

Synthetic biology

Microbiome research and applications

Biotechnology innovation and commercialization

Research and development

Strategic leadership and entrepreneurship

Securing funding and strategic partnerships

Professional Impact

Under Cyrille's visionary leadership, Abolis Biotechnologies has emerged as a prominent player in the biotechnology industry, developing cutting-edge solutions that address pressing challenges across various sectors. Through his work at Microbiome Studio, he continues to drive the advancement of microbiome research and its translation into practical applications that improve human health and sustainability.

Conclusion

Cyrille Pauthenier's diverse experience, technical expertise, and entrepreneurial drive have positioned him as a leading figure in the biotechnology industry. As the Founder, Owner, and CEO of Abolis Biotechnologies, and the Founder and President of Microbiome Studio, he is consistently at the forefront of innovation, contributing to the development of transformative biotechnology solutions that have a tangible impact on the world.